openPR Logo

Press Releases from Kuick Resarch (821 total)

AE Defense Sector Opportunity Analysis

Over the past few years UAE's defense industry has achieved significant progress and considerable traction, as a result of the guidance and directives from the country’s leadership to broad-base its economic structure and resources to be able to reduce dependence on oil by 2030. While the larger focus is on developing local industries and manufacturing, the development of the defense industry is a specific but crucial aspect of that wider

China Aviation Industry Opportunity Analysis

Aviation industry in China began way back in 1951 with some domestic travel and agricultural services being their primary goals. Greater growth happened much later in the mid seventies. The industry posted major growth in its revival phase between 1977 and 1996. After 1996, there was a general period of growth in the economy and this reflected in the volume of general aviation operations and services that have increased throughout

South Korea Biosimilar Market Analysis

South Korea has emerged as one of the strategic location for the development of biosimilars on the global level. Among the various emerging countries identified for development of biosimilars, South Korea is one of the most promising countries where pharmaceutical companies have identified huge investment potentials for the drug development process. One of the major reasons for the attractiveness of South Korea is the end of patent protection for some

India Ayurvedic Cosmetics Market Opportunity Analysis 2018

Consumers worldwide are going green and this is especially true in the cosmetics market. Over the last few years, growth in the market for cosmetics has been driven by products that use natural or herbal components. The market share of natural based products has been increasing gradually. Companies are increasingly feeling pressurized to focus on sustainability and reduce their environmental footprints. Consumers are more aware and better informed than ever

India Specialty Clinics Market Opportunity Analysis 2018

Specialty clinics are emerging out of the general hospitals as a universal trend. Globally, niche specialties are being catered to by specialty clinics. The share of single specialty clinics, though is small, is rapidly growing in India. The market for specialty clinics is highly fragmented in India, with the presence of many small and niche players. However, the popularity of these clinics is increasing day-by-day. In 2013, specialty clinics accounted

UAE Diabetes Market Opportunity Analysis 2018

UAE, with one of the highest rates of Type 2 diabetes represents significant societal costs, in relation to morbidity, mortality and also lost productivity coupled with a huge burden on the healthcare system. It has been observed that the high prevalence of diabetes in the UAE is gradually taking its toll on the overall health of the nation and also risking the country’s economic well-being. The total number of diabetes patients

Shire - Cancer Drugs Clinical Pipeline Insight

“Shire - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Shire. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “19” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There are 5 cancer drugs by Shire which are commercially available in the

Spirogen - Cancer Drugs Clinical Pipeline Insight

“Spirogen - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Spirogen. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader

Taiho Pharmaceutical - Cancer Drugs Clinical Pipeline Insight

“Taiho Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Taiho Pharmaceutical. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline and majority of them are in phase-I. There are 7 cancer drugs by Taiho Pharmaceutical which are commercially available

Takaro Bio - Cancer Drugs Clinical Pipeline Insight

“Takaro Bio - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Takaro Bio. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline and majority of them are in phase-I. The report includes all the relevant information with respect to development of

Takeda -Cancer Drugs Clinical Pipeline Insight

“Takeda -Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Takeda. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “27” cancer drugs in clinical pipeline and majority of them are in research phase. There are 16 cancer drugs by Takeda which are commercially available in the market.

Australia Shale Gas Industry Analysis

One of the world’s largest natural gas exporters has found a new resource to boost up its profile. While the conventional natural gas reserves seem to be never ending in Australia, it has started tapping its unconventional resources. Australia is sitting on nearly 6% of the world’s shale gas reserves, i.e. 437 Trillion Cubic Feet. These are in addition to its already proven natural gas and oil reserves that

Transgene - Cancer Drugs Clinical Pipeline Insight

“Transgene - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Transgene. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in preclinical phase. The report includes all the relevant information with respect to development of cancer drugs

COPD Drug Market Opportunity & Clinical Pipeline Analysis

Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the

Transdermal Drug Delivery Market & Clinical Pipeline Insight

Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through the layers of

WILEX AG - Cancer Drugs Clinical Pipeline Insight

“WILEX AG - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by WILEX AG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “7” cancer drugs in clinical pipeline and majority of them are in preclinical phase. The report includes all the relevant information with respect to development of

Vertex Pharmaceutical - Cancer Drugs Clinical Pipeline Insight

“Vertex Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Vertex Pharmaceutical. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in phase-I. The report includes all the relevant information with respect to development of

Yakult Honsha - Cancer Drugs Clinical Pipeline Insight

“Yakult Honsha - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Yakult Honsha. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “5” cancer drugs in clinical pipeline and majority of them are in phase-II. There are 3 cancer drugs by Yakult Honsha which are commercially available

Yuhan - Cancer Drugs Clinical Pipeline Insight

“Yuhan - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Yuhan. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader

Global Orphan Drug Clinical Pipeline Insight 2022

“Global Orphan Drug Clinical Pipeline Insight 2022” report gives comprehensive insight on various clinical and non-clinical aspects associated with ongoing clinical trials of 808 orphan designated drugs across the globe. The in-depth clinical insight presented in the report helps the reader to analyze and identify the various stakeholders involved in the clinical development and commercialization of orphan designated drugs in the global market. Currently there are more than 300 orphan

Global HIV Infection Drug Market & Pipeline Insight

The rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.5 in 2013, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to

Pulmonary Drug Delivery Market & Clinical Pipeline Insight

The demand for new and innovative drug delivery systems has been on a rising trend with the pharmaceutical companies concentrating on developing innovative methods for this area. It is the result of these continued efforts, which have led to the ever rising popularity of pulmonary drug delivery methods across the globe. Pulmonary drug delivery system uses the respiratory tract to deliver drugs into the lungs in order to treat diseases

Antibody Drug Conjugate Market Opportunity Analysis

Ever since the first attempt in the 1980's to use antibody-based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the

Controlled Release Drug Delivery Market & Pipeline Insight

Controlled drug delivery refers to a system combining the formulation components and devices with the objective of releasing a drug at a predictable rate. The controlled drug delivery system makes it possible in vivo, irrespective of whether the administration of the drug is done through the injected or non-injected route. A controlled drug delivery is observed to occur when a natural or a synthetic polymer is carefully combined with a

Nanoparticle Drug Delivery Market & Clinical Pipeline Insight

Drug delivery technologies currently occupy a significant position in the pharmaceutical industry. It has become so important that the mode of delivery of drugs has come to define the efficiency and marketability of those drugs. The pharmaceutical industry is witnessing a shift in the focus of the stakeholders towards newer systems of drug delivery in order to achieve efficient and safe transportation of novel products and formulations. There have

Cancer Cell Therapy Market & Pipeline Insight

Since the past 3-5 years, a more complex therapeutic modality has been is emerging as cell therapies which have been developed to treat diseases which are not amenable to treatment with more classical pharmaceutical or biopharmaceutical products. This market offers the promise of successfully regenerating damaged tissues and organs in the body by replacing the damaged tissue and/or by stimulating the body’s own repair mechanisms to heal previously irreparable tissues.

Emerging Renewable Energy Implementation in GCC

GCC region is shifting focus from its most prized asset, hydrocarbons. Oil and gas, though, still dominates the trade in and out of the GCC Region but it is looking to develop its renewable sources of energy as well. All the GCC countries have started to take the renewable energy way, contrary to their most important possession, non renewable (Hydrocarbons). The growing economy with growing population has affected a growth

Global Orphan Cancer Drug Market & Clinical Pipeline Insight

The drug development strategies of the pharmaceutical companies is undergoing a paradigm shift from manufacturing traditional essential medicines to orphan drugs due to significant competition from generics and the associated economic situation. The returns on investment from orphan drugs are expected to help the pharma companies to overcome the impact of revenue loss due to expiry of patents of blockbuster drugs. The major drivers for companies to increasingly invest in

Cancer Immunotherapy Market & Clinical Pipeline Insight

With more than 6 Million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced by almost all the economies of the world. Inspite of the fact that there have been significant improvisation and advancements in surgery, radiation therapy, and chemotherapy over the years, there has hardly been any significant control of this disease by these treatments. There have been many developments in the recent

China Space Industry Development Analysis

The space Industry today plays an important role in China’s comprehensive development strategy. The space sector enjoys a special status and its contribution and performance cannot be judged by macroeconomic and other aggregate national level indicators. China’s investment in space in the last 2-3 decades have focused on capabilities that directly serve economic goals, aid development and have potential for contribution to economic development. However economic development was not the

Saudi Arabia Pharmaceutical Market Development Analysis

The Saudi Arabia Pharmaceutical market has recorded significant growth over the years driven by various factors like increasing ageing population mostly in the above 60 years bracket, changing demographics and rise in the incidence of lifestyle diseases, increased spending power, result driven government initiatives to promote the growth of indigenous pharmaceutical companies. Inspite of the progress, the pharmaceutical sector in the Saudi Arabia is still in an emerging phase, and

Global Biosimilars Market Regulations & Pipeline Insight

The evolution of biosimilars has currently reached different stages across the world. Owing to variable clarity in the guidelines and diverse regulatory pathways, various definitions of biosimilars (or the broader group of follow-on biologics) have emerged across countries. Till now the European region has the best-established framework for biosimilars. The US is currently almost aligned to the European standards. Biosimilars are also known as follow on biologics in the

Global Intranasal Drug Delivery Market & Pipeline Insight

Intranasal drug delivery has evolved in the recent years as a significant method of delivering drugs through the nasal route. This method has been identified to have all the potential to achieve significant milestones in the pharmaceutical industry, as it is largely driven by its capability to cure local infections and chronic allergies. The human nose, which has a unique vascular structure, makes it specifically accessible for delivering small molecule

Recombinant Therapeutic Proteins Market & Pipeline Analysis

Proteins are known to be the building blocks of life, and as a part of the natural metabolism, they are synthesized by all living forms. Some proteins, such as enzymes, tend to serve as biocatalysts, which help in increasing the rate of metabolic reactions. There are other types of proteins which form the cytoskeleton. There is a significant role played by proteins in functions like cell signaling, immune responses, cell

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

The recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to the achievement of significant number of regulatory milestones during this period. The use of mAbs for treating cancer has increased significantly. The rising market availability

Europe Biosimilars Market & Pipeline Insight

Biosimilars have emerged as one of the most promising segment of the European pharmaceutical industry in recent years. The biosimilars segment has been experiencing a steady growth driven by patent expiration of blockbuster drugs, amenable regulatory framework, economic incentives along with favorable pricing and reimbursement policies adopted across multiple markets in Europe. The current biosimilars market is highly fragmented in nature due to their accessibility in various therapeutic categories. The

Global Cancer Kinase Inhibitors Market & Pipeline Insight

The recent years have witnessed the emergence of kinase inhibitors, which have the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past two decades, the researchers have increased their learning about the functioning of these inhibitors, which has led to the achievement of significant milestones of development during this period. The use of inhibitors for treating cancer is gradually increasing. The rising market availability

Global Gene Therapy Market & Pipeline Insight

There have been significant advancements in the area of gene therapy in terms of research of new drugs. Over the past 20 years, the gene therapy market has witnessed significant advances ranging from the stage of conception, to the current stage of clinical trials for various disease conditions. When compared to other conventional methods such as radiotherapy and chemotherapy, gene therapy enjoys a clear advantage mainly because this therapy does

US Shale Gas Industry Analysis

Shale gas has emerged as one of the sought after investments areas in the energy sector, especially in the US. Combined with the technical advances that have helped access huge and previously inaccessible natural gas reserves and the production capability in the industry, there has been increased interest in the US shale gas industry, both on the production and exploration side. The first commercial shale gas well was drilled in

Global Breast Cancer Vaccine Clinical Trial Insight

“Global Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: * Global Breast Cancer Vaccine Market Overview * Global Breast Cancer Vaccine Clinical Pipeline by Company, Phase & Country * Mechanism of Breast Cancer Vaccine & Personalized Cancer Vaccines * Detailed Clinical Insight on Breast Cancer Vaccine Pipeline: 35 Vaccines * Majority in PHASE-I Clinical Trial: 12 Vaccines * Highest Clinical Phase is PHASE-III: 2 Vaccines (NeuVax & OBI-822) Cancer vaccines have emerged viable option for treating

UAE IVF Treatment Market Outlook 2018

UAE has been projected as one of the upcoming IVF market meeting all international health expectations and standards in terms of quality of services provided without discrimination. It bears a potential to become a hub for promoting medical tourism keeping in mind the recent changes that have been introduced by the government, healthcare facilities that meet international standards and the well qualified doctors that are willing to serve here. The country

Ebola Virus Vaccine Market & Pipeline Insight

Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targeted therapeutics for lung cancer treatment are major market contender in global market with wide acceptance levels among oncologists and patients. Chemotherapeutics have life threatening side effects

Transdermal Patch Market & Pipeline Insight 2015

Technological progress is continuously increasing allowing pharmaceutical companies to develop newer products with higher pharmacological benefits. Transdermal patches are extension of their continuous efforts due to which several patients have been able to improve quality of life. This market segment has yet to be tapped as only few disease indications are being covered under their treatment. Pharmaceutical companies are increasing their investments in research and development segment to introduce novel

Global Skin Cancer Vaccine Market & Pipeline Insight 2015

Skin cancer incidences are increasing at alarming rates across the world causing high morbidity and mortality. Research and development in field is expected to change the present scenario by providing better therapeutic options for patients. Skin cancer therapeutics available in market used for first-line treatment have modest efficacy which lays emphasis on the development of better products like skin cancer vaccines. Cancer vaccines for different disease indications have proved their

Global Non Small Cell Lung Cancer Market & Pipeline Insight

Lung cancer has become one of the most prevalent cause of cancer related morbidity and mortality in past several decades across the world. Lungs are a pair of spongy tissues present in the thoracic cavity responsible for gaseous exchange from the surrounding environment. These tissues could be easily damaged by the toxins present in environment and cells may show cancerous growth upon longer exposure. The lung cancer is a collective

Global Peptide Vaccine Market & Pipeline Insight

Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen attack. Every living cell in human body has surface markers as an instrument to

Dendritic Cell Cancer Vaccine Market & Clinical Insight

Dendritic cells are branched cells found in lymphoid organs and they are responsible for antigen display and T-cell activation. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. In 1868, Paul Langerhans discovered dendritic cells and thought that they are part of nervous system because of their branched structure. Until 1973 their identity was mistaken, Ralph Steinman and Zanvil Cohn identified them

US Proton Therapy Market Opportunity Analysis

Proton beam therapy is seen as the next great leap forward in treating cancer with radiation. It has been found that proton therapy is beneficial for tumors surrounded by sensitive structures such as the eye, brain, and spinal cord, where the organs are sensitive and there is high potential for radiation damage. Proton therapy is also very useful in childhood cancer treatment due to the high risk of long-term side

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment. Past few decades have witnessed an increased level of activity with regards to development of new identification systems and drug mechanisms. In recent years, there have been an increasing number of

Go To Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 15 17